Suero, Mark Kloe C.

HRN: 22-28-62  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/05/2022
12/11/2022
IVT
65mg
Q24hrs
Pcap C
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes